netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Sorafenib found 6 matches
Open monograph to display formulary status BNF Category
  Sorafenib  (Nexavar®) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Cytotoxic Drug Regorafenib  (Stivarga® ) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NHS England Specialised Commissioning Policy: Sorafenib maintenance for adults with FLT3-internal tandem duplication (FLT3-ITD) acute myeloid leukaemia (AML) undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT)  (08.01.05)
link in drug section NICE TA 535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (08.01.05)
link in drug section NICE TA 535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (08.01.05)
link in drug section NICE TA474 Sorafenib for treating advanced hepatocellular carcinoma (08.01.05)


 
netFormulary